Aircast buy brings dj Orthopedics more orthopaedic rehab lines and greater international reach
This article was originally published in Clinica
Executive Summary
In a bid to strengthen its core non-operative orthopaedics business, dj Orthopedics is to acquire Aircast, a privately-held company with 30 years of history in cast manufacturing, for $290m in cash. The transaction is expected to close as early as March 30, subject to regulatory and shareholder approvals.
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.